Human Papillomavirus: Clinical Trials

6 trials for Human Papillomavirus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 4, Terminated 1, Unknown 1
Phase 21Completed 1

Follow Human Papillomavirus: new trials by email Literature Review of Human Papillomavirus trials Research Report on Human Papillomavirus

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Bintrafusp Alfa, PDS01ADC, Entinostat - Oropharyngeal Cancer, Neck Cancer
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)552021-10-052026-09-22
Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
Aldesleukin, E6 T Cell Receptor (TCR) - Human Papillomavirus, HPV-16
Phase 1TerminatedNational Cancer Institute (NCI)12018-01-092021-02-16
Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers
GX-I7, Placebo - Human Papillomavirus
Phase 1CompletedGenexine, Inc.322017-02-162018-10-23
A Phase I Clinical Trial of an HPV Therapeutic Vaccine
Vaccine consisting of four HPV-16 E6 peptides in combination with CandinĀ® - Human Papillomavirus
Phase 1CompletedUniversity of Arkansas522012-08-012016-10-12
Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females
HPV 16/18 vaccine, 0,5ml, Placebo control, 0.5ml, HPV 16/18 vaccine, 1.0ml - Human Papillomavirus
Phase 1UnknownShanghai Zerun Biotechnology Co.,Ltd1602012-02-012012-03-08
The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru
Gardasil - Cervical Intraepithelial Neoplasia, Cervical Cancer
Phase 1CompletedPreventive Oncology International, Inc.6422011-05-012014-04-21

Narrower conditions

Uterine Cervical Neoplasms (3)  ·  Anus Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Oropharyngeal Neoplasms (1)  ·  Penile Neoplasms (1)  ·  Squamous Intraepithelial Lesions (1)  ·  Uterine Cervical Dysplasia (1)  ·  Vaginal Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Genital Neoplasms, Female (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Uterine Cervical Diseases (3)  ·  Uterine Diseases (3)  ·  Uterine Neoplasms (3)  ·  Anus Diseases (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)  ·  Interleukin-2 (1)  ·  aldesleukin (1)  ·  bintrafusp alfa protein, human (1)  ·  efineptakin alfa (1)  ·  entinostat (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Genexine, Inc. (1)  ·  Preventive Oncology International, Inc. (1)  ·  Shanghai Zerun Biotechnology Co.,Ltd (1)  ·  University of Arkansas (1)

Countries

United States (3)  ·  China (1)  ·  Peru (1)  ·  South Korea (1)

Top investigators

Carlos Vallejos Sologuren, MD (1)  ·  Hoyoung M Maeng, M.D. (1)  ·  Jae Kwan Lee, MD, PhD (1)  ·  Jerome L Belinson, MD (1)  ·  Mayumi Nakagawa, MD, PhD (1)  ·  Scott Norberg, DO (1)  ·  William W Greenfield, MD (1)  ·  Yan-ping Li, MD (1)

Results publications

PMID 23385153

NIH funding

R01CA143130 (1)